Inclusion compound containing celecoxib and preparation method thereof

A celecoxib and inclusion compound technology, applied in the field of celecoxib inclusion compounds, can solve the problems of difficult micronization, difficult pulverization, and low bulk density of celecoxib raw materials

Inactive Publication Date: 2013-11-27
JIANGSU QINGJIANG PHARMA
View PDF2 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Celecoxib is a white to off-white crystalline powder, easily soluble in methanol, ethanol, acetone and dimethyl sulfoxide, and almost insoluble in water, so oral absorption is poor. In order to improve its bioavailability, the patent number is 99802185.7 The patent literature reports that the D90 of celecoxib particles is less than 200um, preferably less than 100um in D90, more preferably less than 45um in D90, and most preferably less than 25um in D90 and made into preparations according to conventional methods to achieve effective bioavailab

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Inclusion compound containing celecoxib and preparation method thereof
  • Inclusion compound containing celecoxib and preparation method thereof
  • Inclusion compound containing celecoxib and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Recipe composition:

[0016]

[0017] The raw material of celecoxib is self-made by our company, and the approval number is: Guoyao Zhunzi H20133228.

[0018] Preparation method: Weigh the formulated amount of celecoxib, add an appropriate amount of ethanol to dissolve it completely, keep a certain temperature, add the formulated amount of the saturated aqueous solution of the inclusion carrier dropwise, continue stirring for 1 hour, stop heating, and continue stirring to room temperature , to obtain a white suspension, which can be obtained by vacuum drying after filtration, or the white suspension can be directly freeze-dried.

Embodiment 2

[0020] Recipe composition:

[0021]

[0022] Preparation method: Weigh the formulated amount of celecoxib, add an appropriate amount of ethanol to dissolve it completely, keep a certain temperature, add the formulated amount of the saturated aqueous solution of the inclusion carrier dropwise, continue stirring for 1 hour, stop heating, and continue stirring to room temperature , to obtain a white suspension, which can be directly freeze-dried.

Embodiment 3

[0024] Recipe composition:

[0025]

[0026] Preparation method: Weigh the formulated amount of celecoxib, add an appropriate amount of ethanol to dissolve it completely, keep a certain temperature, add the formulated amount of the saturated aqueous solution of the inclusion carrier dropwise, continue stirring for 1 hour, stop heating, and continue stirring to room temperature , to obtain a white suspension, which was obtained by vacuum drying after filtration.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Solubilityaaaaaaaaaa
Login to view more

Abstract

The invention relates to an inclusion compound containing celecoxib and a preparation method thereof. The inclusion compound containing celecoxib comprises celecoxib and an inclusion material, wherein the inclusion material is preferable one or two of beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin; the weight ratio of the inclusion material to the celecoxib is (0.5-10):1. The preparation method comprises the following steps: respectively dissolving the inclusion material and the celecoxib in water and an organic solvent; slowly dropwise adding the saturated aqueous solution of the inclusion material into the organic solution containing the celecoxib; continuously stirring to form a white suspension; preparing the inclusion compound containing the celecoxib by adopting a vacuum drying or freeze-drying mode. The inclusion compound can be crushed to be prepared into various solid preparations. According to the inclusion compound containing celecoxib, the problem of extremely poor dissolubility of celecoxib in water can be solved, a high-bioavailability solid preparation with stable property can be prepared by adopting a simple and practical process, and the problem that a celecoxib raw material medicine is difficult to crush can be solved.

Description

technical field [0001] The invention relates to a celecoxib inclusion compound, a method for preparing the inclusion compound and a solid preparation containing the inclusion compound. Background technique [0002] Celecoxib is a coxib non-steroidal anti-inflammatory drug. It is a new generation of compounds with a unique mechanism of action, that is, it specifically inhibits cyclooxygenase-2. It is mainly used clinically for the treatment of osteoarthritis and rheumatoid arthritis. Treatment and adjuvant treatment of familial adenomatous polyps, this variety was approved for marketing in the United States in 1998. In September 2000, the State Food and Drug Administration approved the import sub-packaging of celecoxib of Pfizer Pharmaceuticals Co., Ltd. and put it on the market in China. So far, celecoxib has been approved for marketing in dozens of countries (regions). [0003] Celecoxib is a white to off-white crystalline powder, easily soluble in methanol, ethanol, acet...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K47/48A61K31/635A61P29/00
Inventor 史红霞
Owner JIANGSU QINGJIANG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products